|
|
| |
| |
 |
 |
| ImQuest BioSciences strives to provide research and development services to the highest scientific standards and expects that data provided by the laboratories will be suitable for publication in peer reviewed journals, in Investigational New Drug applications with the FDA, as components of due diligence resulting in licensing opportunities, and as presentations at international meetings and workshops. The greatest source of pride for ImQuest is the acceptance of manuscripts, the funding of grants and contracts and the acceptance of INDs and meeting presentations because these submissions are reviewed by our scientific peers and judged worthy. Please take a moment and share some of ImQuest’s recent successes. |
|
| Testimonials: |
|
IND submitted by The Procter & Gamble Company for human testing of FB632 for HIV infection. ImQuest preclinical data was included as part of an IND submitted by The Procter & Gamble Company for human testing of FB632 in HIV infected patients.
More Testimonials» |
|
|
|
 |
| ImQuest News: |
- Dr. Robert Buckheit has been named to head the Program Committee for the 2008 International Conference on Antiviral Research to be held in Montreal, Canada. Dr. Buckheit will be responsible for the organization of the 2008 meeting and is currently hard at work on the selection of plenary speakers and symposium sessions. This years meetng will feature a session on the development of inhibitors to novel HIV targets. More»
- Dr. Robert Buckheit (PI) and ImQuest have received a Phase 2 SBIR from the NIH to continue the development of the pyrimidinedione anti-HIV compounds as topical microbicides. The Phase 2 award will be performed in collaboration with Patrick Kiser at The University of Utah who will be working on the development of a formulated topical microbicide product. More»
- A manuscript authored by Robert Buckheit, Tracy Hartman and Karen Watson has been accepted for publication in Antiviral Chemistry and Chemotherapy. This work details the structure activity relationships among the pyrimidinedione HIV inhibitors. More»
- ImQuest announces the successful completion of the first development milestone in their work with International Partnership for Microbicides and progression to advanced toxicology and formulation studies for development of the pyrimidinedione topical microbicides. More»
- ImQuest announces the initiation of studies supported by The International Partnership for Microbicides to develop the viral inactivating NCp7 inhibitors as potential topical microbicides. More»
- ImQuest staff will be attending the DART-Hepatitis meeting in December 2007. More»
- Dr. Robert Buckheit has been nominated for the position of President of the International Society for Antiviral Research (ISAR). More»
- ImQuest BioScience’s staff will be presenting three abstracts at the International Conference on Antiviral Research (ICAR) being held in Puerto Rico, May 7-11, 2006. More»
- ImQuest announces the formation of a strategic drug development alliance with Samjin Pharmaceuticals, Inc. Ltd. Of Seoul KOREA as well as the licensing of the entire pyrimidinedione series of agents for HIV therapy. More»
- ImQuest announces the licensing of ISIS 5320 from ISIS Pharmaceuticals, Inc. for development as a anti-HIV topical microbicide. More»
- ImQuest staff will be attending the American Society of Microbiology General Meeting in Orlando and the American Association of Pharmaceutical Science Biotechnology meeting in Boston this summer. More»
|
|
| Press Releases |
|
| |
|
| Research and Development News of Interest |
Look For ImQuest Staff at the Following Upcoming Conferences
- International Conference on Antiviral Research, April 13-17, 2008, Montreal, Canada
- American Association of Pharmaceutical Science-Biotechnology: June 22- 25, 2008, Toronto, Canada.
- International HIV Drug Resistance Workshop: June 10 - 14, 2008, Sitges, Spain
- Interscience Conference on Antimicrobial Agents and Chemotherapy: October 25 - 28, 2008 Washington, DC
- Mid-Atlantic Bio: October 25- October 26, Bethesda, MD
- DART-HIV: December 9 - 12, 2008, Peurto Rico
|
| |
|
|
| |
| |
| Copyright © 2006, ImQuest BioSciences. | | | |
| | | | | |
| | | | |
| |
|
|
|
